Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
02/03/2011 | WO2011014494A1 ENANTIO- AND STEREO-SPECIFIC SYNTHESES OF β-AMINO-α- HYDROXY AMIDES |
02/03/2011 | WO2011014128A1 Small molecule inhibitors of isoprenylcysteine carboxyl methyltransferase with potential anticancer activity |
02/03/2011 | WO2011013752A1 Pharmaceutical composition containing fused hetero-ring derivative |
02/03/2011 | WO2011013624A1 Indole derivative and pharmacologically acceptable salt thereof |
02/03/2011 | WO2011013623A1 Indole derivative and pharmacologically acceptable salt thereof |
02/03/2011 | WO2011013597A1 Fullerene derivatives |
02/03/2011 | WO2011013558A1 Indole derivative |
02/03/2011 | US20110028474 Protein kinase and phosphatase inhibitors |
02/03/2011 | US20110028468 Compounds having npy y5 receptor antagonistic activity |
02/03/2011 | US20110028463 Amide compounds |
02/03/2011 | CA2768838A1 Enantio- and stereo-specific syntheses of beta-amino-alpha- hydroxy amides |
02/03/2011 | CA2768816A1 Indole derivative or pharmaceutically acceptable salt thereof |
02/03/2011 | CA2768814A1 Indole derivative or pharmaceutically acceptable salt thereof |
02/02/2011 | EP1020179B9 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
02/02/2011 | CN101962390A Fluorescently tagged ligands |
02/02/2011 | CN101962366A Diphenyl thioether linked bis-imidazoline ligand compound and preparation method thereof |
02/01/2011 | US7880020 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors |
02/01/2011 | US7880019 9-[N-phenyl-N-(9-phenylcarbazol-3-yl)amino]-10-phenylanthracene; high luminous efficiency; long lifetime |
02/01/2011 | US7879900 Antiinflammatory agents; antitumor agents; Alzheimer's disease;atherosclerosis |
02/01/2011 | US7879893 Zinc binding ligand; sustained release of insulin |
02/01/2011 | US7879876 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
02/01/2011 | US7879863 Aniline derivatives |
02/01/2011 | US7879791 Regulation of T cell-mediated immunity by tryptophan |
02/01/2011 | CA2560547C Formamide derivatives useful as adrenoceptor |
02/01/2011 | CA2454120C Taxol enhancer compounds |
02/01/2011 | CA2380857C Substituted 2-dialkylaminoalkylbiphenyl derivatives |
02/01/2011 | CA2351707C Crystal modification b of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid |
01/27/2011 | WO2011011330A2 Inhibitors of d-amino acid oxidase |
01/27/2011 | WO2011011186A2 Hdac inhibitors and therapeutic methods using the same |
01/27/2011 | WO2011010844A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
01/27/2011 | WO2011010748A1 Indole derivative and saltiness-strengthening agent containing the derivative |
01/27/2011 | WO2011010589A1 Fullerene derivative |
01/27/2011 | WO2011010013A1 Acyl guanidine derivatives modulating the hedgehog protein signaling pathway |
01/27/2011 | WO2010104324A3 Halogenated isoindole compounds with superior binding affinity to beta-amyloid aggregates and fibrils, method for preparing same, and use thereof |
01/27/2011 | WO2009116069A3 Process for preparation of 1-(9h-carbazol-4-yloxy)-3-[[2-(2- methoxyphenoxy) ethyl] amino]-2-propanol |
01/27/2011 | US20110021785 Novel indole derivatives as selective androgen receptor modulators (sarms) |
01/27/2011 | US20110021784 Methods for Preparing Diazonamides |
01/27/2011 | US20110021594 Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof |
01/27/2011 | US20110021556 Pyrrolidinyl derivatives and uses thereof |
01/27/2011 | US20110021543 Heterocyclic compounds and their use as pesticides |
01/27/2011 | US20110021540 Bis-(Sulfonylamino) Derivatives in Therapy 066 |
01/27/2011 | US20110021528 Novel hydroxamates as therapeutic agents |
01/27/2011 | US20110021480 17-beta HSD1 and STS Inhibitors |
01/27/2011 | CA2769474A1 Acyl guanidine derivatives modulating the hedgehog protein signaling pathway |
01/26/2011 | EP2278637A1 Complexes of form L2MX |
01/26/2011 | EP2277862A2 5-hydroxy-4-aminomethyl-1-cyclohexane or (cycloheptyl)--3-alkoxycarbonyl indole derivatives, pharmaceutically acceptable antiviral salts thereof and a method for the production thereof |
01/26/2011 | EP2277858A1 Amide compound |
01/26/2011 | EP2277519A2 Use of Angiotensin II type 1 receptor antagonists for the prevention of stroke, diabetes and/or congestive heart failure |
01/26/2011 | EP2276732A1 Novel estrogen receptor ligands |
01/26/2011 | EP1554239B1 Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists |
01/26/2011 | EP1480941B1 Urea derivatives as hiv aspartyl protease inhibitors |
01/26/2011 | CN1726603B Charge transport compositions and electronic devices made with such compositions |
01/26/2011 | CN101959857A Compound for organic electroluminescent device and organic electroluminescent device using the same |
01/26/2011 | CN101959856A Preparation of lenalidomide |
01/26/2011 | CN101628190B Filtration and drying integrated device used in rubber antiscorcher CTP production process and application thereof |
01/26/2011 | CN101128426B Method for the preparation of bis(haloimides) |
01/26/2011 | CN101104601B Method for preparing zafirlukast important intermediate |
01/26/2011 | CN101084190B 2,3,4,9-tetrahydro-1H-carbazole derivatives as CRTH2 receptor antagonists |
01/26/2011 | CN101058561B Diphenylurea derivative for inhibiting protein kinase, and composition and use thereof |
01/25/2011 | US7875748 Prepared by reaction of tetraphenylcyclopentadienone with 1,4-diethynyl-2,5-dimethoxybenzene; can be used as a core material for an organic electroluminescence element or other optical devices |
01/25/2011 | US7875730 Process for manufacture of racemic Carvedilol |
01/25/2011 | US7875712 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
01/25/2011 | US7875605 1-Benzenesulfonyl-3-(4-methylpiperazin-1-ylmethyl)-5-nitro-1 H-indole; 1-[[5-Bromo-1-(2-Bromo-4-methoxybenzenesulfonyl)-indo1-3-yl]methyl][1,4]diazepane; useful for treating psychotic and neurodegenerative disorders e.g. schizophrenia, Alzheimer's disease, Parkinson's disease and Huntington's chorea |
01/25/2011 | CA2490141C 1-[(indol-3-yl)carbonyl]piperazine derivatives |
01/25/2011 | CA2472776C Process for the manufacture of hmg-coa reductase inhibitors |
01/25/2011 | CA2458528C C2-substituted indan-1-ones and their derivatives, processes for their preparation and their use as medicaments |
01/25/2011 | CA2454532C Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
01/20/2011 | WO2011009021A1 Processes for the synthesis of (2s, 3ar, 7as)-octahydro-1h-indole carboxylic acid as an intermediate for trandolapril |
01/20/2011 | WO2011008169A1 Organic ambipolar light emitting materials |
01/20/2011 | WO2011008168A1 Organic light emitting materials |
01/20/2011 | WO2011006803A1 3-0x0-2, 3, -dihydro-lh-isoindole-4-carboxamides with selective parp-1 inhibition |
01/20/2011 | WO2011006794A1 3-oxo-2, 3-dihydro-lh-isoindole-4-carboxamides as parp inhibitors |
01/20/2011 | WO2010102758A3 Halogenalkylmethylenoxy-phenyl-substituted ketoenols |
01/20/2011 | US20110015375 Methods for Identifying and Using MarR Family Polypeptide Binding Compounds |
01/20/2011 | US20110015247 Novel crystalline form of carvedilol dihydrogen phosphate and related processes |
01/20/2011 | US20110015235 Novel phenylethynyl derivatives of 8-aza-bicyclo[3.2.1]octane and their use as monoamine neurotransmitter re-uptake inhibitors |
01/20/2011 | US20110015180 Chemokine receptor antagonists |
01/20/2011 | US20110015158 Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
01/20/2011 | US20110014120 Trifunctional imaging agent for monoclonal antibody tumor-targeted imaging |
01/20/2011 | DE102009034189A1 New (aza)phthalocyanine compounds useful e.g. to prepare a composition for photodynamic chemotherapy of tumors, as a part of an active layer to prepare and operate photovoltaic cells, and as main or addition components in printing ink |
01/20/2011 | CA2768239A1 Processes for the synthesis of (2s, 3ar, 7as)-octahydro-1h-indole carboxylic acid as an intermediate for trandolapril |
01/19/2011 | EP2275412A1 Indole and benzimidazole derivatives |
01/19/2011 | EP2275403A1 Process for phenylacetic acid derivatives |
01/19/2011 | EP2275395A2 Copper-catalyzed formation of carbon-carbon bonds |
01/19/2011 | EP2274283A1 Novel n-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds |
01/19/2011 | EP2274282A1 Compounds for use in stabilizing p53 mutants |
01/19/2011 | CN101952251A Carbazole-based hole transport and /or electron blocking materials and /or host polymer materials |
01/19/2011 | CN101952250A Carbazole derivative, and light-emitting element, light-emitting device, and electronic device using carbazole derivative |
01/19/2011 | CN101951901A Use of phthalimide derivatives in the treatment of diseases |
01/19/2011 | CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same |
01/19/2011 | CN101948420A Preparation method for separating and purifying tryptophan monomers from nitraria fruit juice |
01/19/2011 | CN101948366A Method for preparing 4-(diphenylamino)biaryl compound in water phase |
01/19/2011 | CN101362731B Heterocyclic compounds and methods of use |
01/19/2011 | CN101328144B Method for synthesizing indoline and derivates thereof |
01/19/2011 | CN101245044B Method for extracting biphenyl and indole from recycling washing oil of coal oil |
01/18/2011 | US7872021 Liver X receptors (LXR) modulators such as 1-[[4-(1,1-dimethylethyl)phenyl]sulfonyl]-4-methoxy-N-(2-phenyl ethyl)-2,3-dihydro-1H-)indole-2-carboxamide, used for the treatment of atherosclerosis, dyslipidemia, obesity, diabetes, hypercholesterolemia, neurodegenerative diseases and inflammatory diseases |
01/18/2011 | CA2511301C Acylsufonamide compounds as inhibitors of rna-dependent rna viral polymerase |
01/18/2011 | CA2493310C 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition |
01/13/2011 | WO2011004182A1 Intermediates and processes for the preparation of 4- (acetylamino) ) -3- [ (4-chloro-phenyl) thio] -2-methyl-1h-indole-1-acetic acid |
01/13/2011 | WO2010115252A9 PHTHALIMIDE DERIVATIVES OF NON-STEROIDAL ANTI-INFLAMMATORY COMPOUNDS AND/OR TNF-α MODULATORS, METHOD FOR PRODUCING SAME, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND USES THEREOF FOR THE TREATMENT OF INFLAMMATORY DISEASES |